PAPER Peters O
SEARCH RESULTS
329930 RESULTS
PAPER Zhao H, Tang W, Xu X, Zhao Z, Huang L
Functional Magnetic Resonance Imaging Study of Apathy in Alzheimer's Disease.
J Neuropsychiatry Clin Neurosci. 2014 Feb 25; PubMed: 24570144PAPER Chatani E, Imamura H, Yamamoto N, Kato M
Stepwise organization of the β-structure identifies key regions essential for the propagation and cytotoxicity of insulin amyloid fibrils.
J Biol Chem. 2014 Apr 11;289(15):10399-410. Epub 2014 Feb 25 PubMed: 24569992PAPER Kumfor F, Irish M, Leyton C, Miller L, Lah S, Devenney E, Hodges JR, Piguet O
Tracking the progression of social cognition in neurodegenerative disorders.
J Neurol Neurosurg Psychiatry. 2014 Feb 25; PubMed: 24569686PAPER Sepulveda-Falla D, Barrera-Ocampo A, Hagel C, Korwitz A, Vinueza-Veloz MF, Zhou K, Schonewille M, Zhou H, Velazquez-Perez L, Rodriguez-Labrada R, Villegas A, Ferrer I, Lopera F, Langer T, De Zeeuw CI, Glatzel M
Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.
J Clin Invest. 2014 Apr 1;124(4):1552-67. Epub 2014 Feb 24 PubMed: 24569455PAPER Stefanits H, Wesseling C, Kovacs GG
Loss of Calbindin immunoreactivity in the dentate gyrus distinguishes Alzheimer's disease from other neurodegenerative dementias.
Neurosci Lett. 2014 Apr 30;566:137-41. Epub 2014 Feb 23 PubMed: 24569123PAPER Chakravarthy B, Ito S, Atkinson T, Gaudet C, Ménard M, Brown L, Whitfield J
Evidence that a synthetic amyloid-ß oligomer-binding peptide (ABP) targets amyloid-ß deposits in transgenic mouse brain and human Alzheimer's disease brain.
Biochem Biophys Res Commun. 2014 Mar 14;445(3):656-60. Epub 2014 Feb 22 PubMed: 24569075PAPER Hooshmand B, Lökk J, Solomon A, Mangialasche F, Miralbell J, Spulber G, Annerbo S, Andreasen N, Winblad B, Cedazo-Minguez A, Wahlund LO, Kivipelto M
Vitamin d in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes.
J Gerontol A Biol Sci Med Sci. 2014 Sep;69(9):1132-8. Epub 2014 Feb 25 PubMed: 24568931PAPER Noh H, Seo H
Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation.
Neuroscience. 2014 Apr 25;266:255-65. Epub 2014 Feb 22 PubMed: 24568732PAPER Jain P, Karthikeyan C, Moorthy NS, Waiker DK, Jain AK, Trivedi P
Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease.
Curr Drug Targets. 2014 May;15(5):539-50. PubMed: 24568585PAPER Emanuele E
Can trehalose prevent neurodegeneration? Insights from experimental studies.
Curr Drug Targets. 2014 May;15(5):551-7. PubMed: 24568549PAPER Viayna E, Sola I, Bartolini M, De Simone A, Tapia-Rojas C, Serrano FG, Sabaté R, Juárez-Jiménez J, Pérez B, Luque FJ, Andrisano V, Clos MV, Inestrosa NC, Muñoz-Torrero D
Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents.
J Med Chem. 2014 Mar 27;57(6):2549-67. Epub 2014 Mar 10 PubMed: 24568372PAPER Touboul D, Gaudin M
Lipidomics of Alzheimer's disease.
Bioanalysis. 2014 Feb;6(4):541-61. PubMed: 24568356PAPER McCaffrey R, Park J, Newman D, Hagen D
The effect of chair yoga in older adults with moderate and severe Alzheimer's disease.
Res Gerontol Nurs. 2014 Jul;7(4):171-7. Epub 2014 Feb 26 PubMed: 24568209PAPER Karch A, Raddatz LM, Ponto C, Hermann P, Summers D, Zerr I
Diagnostic profiles of patients with late-onset Creutzfeldt-Jakob disease differ from those of younger Creutzfeldt-Jakob patients: a historical cohort study using data from the German National Reference Center.
J Neurol. 2014 Feb 26; PubMed: 24570280Current Filters
No filters selected